Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com 

Vicor's efficient delivery of key power modules is part of the case for Cerebras meeting and exceeding its 2028-29 numbers. As models improve, more security breaches and deployments should make Cerebras look increasingly like a cybersecurity play. Its revenue ramp looks constrained by capacity, not yet by demand. Bullish on Cerebras but cautious on the broader market, with no short-term earnings prediction. x.com  x.com  x.com  x.com 

Cerebras is wildly overvalued after opening its debut up 102%, at about 157.8x sales. FY25 revenue was $510M against 215.23M shares outstanding, and its $150M net income was not related to its core business. Late buyers risk becoming bag holders. x.com  x.com 

Cerebras may be the only company willing to stitch together a true high-speed solution. If so, it retains upside optionality from high-speed pricing and gains a first-mover advantage. x.com  x.com 

Cerebras is now worth buying after its shares fell into the previously stated $60-$120 buying range. The earlier concern was an out-of-control valuation and providing liquidity to insiders at much higher prices; the shares shown are about $117. x.com 

Cerebras is likely heading lower after terrible earnings, with share unlocks about to add supply. Its valuation was so stretched that it couldn't afford a miss, and it apparently missed; a lot of hope was already built into the price. It could trade around $150 soon. x.com  x.com  x.com  x.com 

Cerebras has significant multi-year upside because its wafer-scale chip does fast inference better than anything else, and latency-sensitive inference is growing about 2x faster than training. Holding the whole model in on-chip SRAM gives up to 15x faster inference than leading GPU solutions; it took OpenAI's fast-inference business from NVIDIA, and management has already raised prices on excess demand. A $20B take-or-pay OpenAI deal for 750MW through 2028 anchors $24.6B of RPO. x.com  x.com 

Cerebras's post-earnings selloff reflects an inability to deliver fast enough yet, not weak demand, a setup like an early Nebius. Its hardware IP delivers the most efficient inference on the market and already draws massive demand from Amazon and OpenAI, on the conviction that inference becomes AI's main demand source and speed the differentiator. What it lacks is infrastructure to scale hardware production and cloud capacity. The open question is whether it can execute as Nebius did. x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras keeps memory on the wafer, which suits agents making many latency-sensitive model calls; it might be the most interesting AI hardware stock to buy now and revisit in three years. UBS estimates revenue rising from $890M in 2026 to $22.6B by 2030 and operating margin from -18% to 46%. At $146, shares trade at about 20x UBS's 2028 earnings and 10x 2029. Execution is everything, but even halfway to those projections, $146 may not look expensive for long. x.com